Cancer Research KI
Cancer Research KI is an overarching umbrella organisation and single point of entry to cancer research at Karolinska Institutet, that includes some 250 research groups. The aim is to combine cancer research with clinical oncology by bringing together top level cancer scientists from different disciplines, with the overall goal to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.
Sign-up to our Newsletter
Previous Newsletters
Researcher Profiles
Organisational Structure
Cancer Research KI News
Blue Sky Grant Recipients 2020
Blue Sky Grant Recipients 2020
Translational Seed Funding Grant Recipients 2020
Translational Seed Funding Grant Recipients 2020
First in Sweden to have OECI accreditation as Comprehensive Cancer Centre
First in Sweden to have OECI accreditation as Comprehensive Cancer Centre
Seminars and Workshops
Global Academic Programs (GAP) Conference - Virtual 17-19 Nov 2020
Global Academic Programs (GAP) Conference - Virtual 17-19 Nov 2020
This 3-day VIRTUAL conference is a forum where MD Anderson Cancer Center and its global network of hospitals, health systems and research institutions collaborate to develop impactful, innovative ideas and research that help MD Anderson achieve its mission.
Cancer Workshop for Patient Organisations - 25 Nov 2020
Cancer Workshop for Patient Organisations - 25 Nov 2020
Joint workshop between Cancer Research KI and RCC Stockholm-Gotland will aim to address opportunities for interaction and communication between patient organisations, researchers and the general public.
Cancer Research KI retreat at Djurönäset 2021
Cancer Research KI retreat at Djurönäset 2021
The XIXth Cancer Research KI Retreat takes place September 27-28, 2021 at Djurönäset in the Stockholm archipelago, gathering Cancer Researchers from Karolinska Institutet and University Hospital for an annual joint scientific meeting.
Grant Announcements
Task Forces for Different Diagnoses (TFDD)
Task Forces for Different Diagnoses (TFDD)
The grants serve as seed funding with aim to encourage KI and University Hospital-based researchers to join forces around one major group of cancers. Each of the task forces was formed to promote interdisciplinary, interdepartmental and translational cooperation. The task forces include all levels of research from bench to bedside, involving basic scientists, nursing scientists, epidemiologists, oncologists, surgeons and other clinicians.
Submission deadline has passed. More information coming soon.
KI and Mayo Clinic Collaborative Call in Breast Cancer
KI and Mayo Clinic Collaborative Call in Breast Cancer
The Mayo Clinic Cancer Center and Karolinska Institutet are pleased to announce the 2020 Request for Applications (RFA) within the area of breast cancer. Having created a unique network, Mayo Clinic Cancer Center and Karolinska Institutet are in an excellent position to leverage this relationship to make a global impact on cancer through research focusing on the diagnosis, prevention, or treatment of breast cancer.
Submission deadline has passed feedback to applicants in fall 2020
Two grant initiatives launched in April 2020
Two grant initiatives launched in April 2020
Cancer Research KI launched two opportunities to apply for research funding in the area of cancer research. The first call named 'Blue Sky Grant', which has also been launched previously, is a “high risk – high reward” type of funding, while the second call named 'Translational Seed Funding' is a new program for novel collaborations between basic and clinical scientists in the area of translational cancer research.
Feedback sent to applicants, awardees can be seen in the Grants section of our website.